"Collaborative Research Opportunities through the MURDOCK Study: Examples & Frontiers"
Thursday June 20, 2013
Time: 12:00 PM to 1:00 PM
Location: Duke North, Room 2002
Directions: Get Map
Speaker/Presenter: Victoria Christian
Series: Grand Rounds
As Chief Operating Officer of the Duke Translational Research Institute (DTRI), Victoria oversees operations of a central institutional resource for translational researchers. In partnership with Director Bruce Sullenger, Victoria built DTRI from the ground up when Duke was first funded by the NIH Clinical and Translational Sciences Award (CTSA). Since then, Ms. Christian has worked with scientists across the Duke Research landscape to realize the potential of platform technologies and core laboratories, implement competitive pilot and seed funding mechanisms, and launch a series of high-impact research programs. Christian¿s background includes a broad range of experiences in clinical and translational research in both industry and academia. In 1990, she joined the Duke Databank for Cardiovascular Disease (the precursor to the DCRI) and worked with Dr. Kerry Lee to coordinate a series of clinical trials in electrophysiology including the Multicenter Un-Sustained Tachycardia Trial (MUSTT), the Mode Selection Trial (MOST), and Sudden Cardiac Death Heart Failure Trial (SCD-HeFT). Between 1997 and 2003, Victoria held senior level positions at PAREXEL International (a global CRO) and King Pharmaceuticals, and co-founded NITROX LLC, a Duke spin-out company in 2004.
<< Back to Calendar